ANTI DIURETIC HORMONE (ADH) / VASOPRESSIN

The Anti Diuretic Hormone (ADH), also called vasopressin, test measures the level of this water-regulating hormone in the blood. ADH is produced in the hypothalamus and stored and released by the posterior pituitary gland. Its main function is to help the kidneys control how much water is retained or excreted in urine. It also contributes to the regulation of blood volume and blood pressure.

When the body loses water or blood becomes concentrated, ADH secretion normally increases. The kidneys then conserve water, producing a smaller volume of more concentrated urine. When the body has sufficient water and blood is more dilute, ADH secretion decreases, allowing the kidneys to produce a larger volume of dilute urine. Abnormal production, release or response to ADH can disturb this balance.

Benefits of the Test

• Measures circulating anti-diuretic hormone or vasopressin.
• Supports the investigation of excessive thirst and frequent urination.
• May assist in evaluating suspected diabetes insipidus.
• Can contribute to the assessment of inappropriate water retention or hyponatremia.
• Provides useful information when interpreted with serum and urine osmolality.
• Helps doctors assess disorders involving the hypothalamus, pituitary gland or kidneys.

Why Doctors Recommend This Test

A doctor may recommend ADH testing when a person has persistent excessive thirst, unusually high urine output, frequent nighttime urination, dehydration or unexplained changes in blood sodium. It may be used as part of the evaluation for diabetes insipidus, a condition in which the body either does not produce enough ADH or the kidneys do not respond appropriately to it.

Central diabetes insipidus may occur when the hypothalamus or pituitary gland cannot produce or release sufficient ADH. Nephrogenic diabetes insipidus occurs when the kidneys do not respond normally to the hormone. ADH results must be assessed in relation to the concentration of the blood and urine because the same measured hormone value can have different meanings under different hydration conditions.

The test may also be considered when inappropriate ADH activity is suspected in a patient with low blood sodium and concentrated urine. This pattern can occur in the syndrome of inappropriate antidiuretic hormone secretion, commonly called SIADH. However, ADH measurement alone does not diagnose SIADH, and doctors generally rely on clinical findings, sodium levels, osmolality and exclusion of other causes.

Preparation Before Test

ADH is sensitive to hydration, posture, stress, exercise, medicines and sample-handling conditions. Follow the exact preparation and collection instructions provided by your doctor and Focus Diagnostics. You may be asked to maintain a specified fluid intake or avoid particular activities before collection. Do not deliberately restrict water unless this has been prescribed and medically supervised.

Tell your doctor about all medicines and supplements, including diuretics, antidepressants, anti-seizure medicines, corticosteroids and hormone treatments. Several medications can influence ADH secretion or water balance. Do not stop any prescribed medicine without medical advice.

The sample requires careful collection, rapid processing and controlled temperature because ADH is unstable. Blood may need to be collected in a pre-chilled tube, separated promptly and frozen according to laboratory requirements. Serum or plasma osmolality, sodium and urine osmolality may be collected at approximately the same time to make the result clinically meaningful.

A water-deprivation test is different from a routine ADH blood test and must never be attempted at home. When required, it is performed under medical supervision because excessive water restriction can cause serious dehydration or dangerous sodium changes.

Normal Reporting Time

ADH or vasopressin measurement is a specialized laboratory investigation and is generally reported within several working days. The exact turnaround time may vary because the sample requires special handling and may be processed in batches or referred to a specialized laboratory. Focus Diagnostics will confirm the applicable reporting schedule during sample collection.

Who Should Take This Test?

This test may be appropriate for people with unexplained excessive thirst, unusually large urine volumes, recurrent dehydration, abnormal blood sodium or suspected disorders of water regulation. It may also be recommended for patients with a history of pituitary or hypothalamic disease, brain injury, neurosurgery or kidney-related resistance to ADH.

ADH testing is not a routine wellness or screening test. It should be performed under medical guidance because interpretation depends strongly on hydration status, blood osmolality, urine concentration and the clinical circumstances present at the exact time of collection.

Detailed Information

A low ADH result may be appropriate when the blood is dilute, but it may be inappropriate when blood osmolality is high. Inappropriately low ADH activity in the presence of concentrated blood and dilute urine may support central diabetes insipidus. In nephrogenic diabetes insipidus, ADH may be normal or increased, but the kidneys do not respond effectively.

An increased ADH level may be an appropriate response to dehydration, blood loss, pain, nausea or physiological stress. In other settings, excessive or inappropriate ADH activity can contribute to water retention and low blood sodium. Various lung, brain, medication-related and systemic conditions may be associated with inappropriate ADH secretion. Therefore, an increased value does not by itself establish SIADH.

ADH concentrations can be difficult to measure because the hormone is unstable and present in very small amounts. Pre-analytical handling can significantly affect the result. Doctors may interpret ADH with serum sodium, plasma osmolality, urine osmolality, urine sodium, kidney function and endocrine assessments. In some clinical settings, copeptin testing may be considered because it is a more stable marker related to vasopressin secretion. Diagnosis and treatment decisions should always be based on the combined clinical and laboratory evidence.